Added to YB: 2025-11-19
Pitch date: 2025-11-17
PRPO [neutral]
Precipio, Inc.
+16.75%
current return
Author Info
Byron Street Research is an investment publication featuring a weekly event-driven idea generator, write-ups modeled in the familiar format of sell-side equity research reports, and performance reviews structured as traditional fund factsheets. Sign up for the newsletter.
Company Info
Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States.
Market Cap
$31.3M
Pitch Price
$21.39
Price Target
N/A
Dividend
N/A
EV/EBITDA
-84.58
P/E
-23.65
EV/Sales
1.43
Sector
Health Care Providers and Services
Category
growth
Catalyst Watch - Precipio, Inc. (PRPO) | Health Care Services
PRPO (earnings): Q3 revenue $6.8M (+30% YOY), Pathology Services +20%, Product Division +16% QOQ. Adj EBITDA $469K vs -$100K YOY, cash ops turned positive from Q2 burn. Margin expansion from volume growth w/o rising COGS. Strong pipeline w/ multiple prospects in trials, new customers going live next 2 quarters.
Read full article (1 min)